179055-21-1 Usage
Pyrazole derivative
A compound based on the pyrazole structure This indicates that the compound is derived from the pyrazole structure, which is a five-membered heterocyclic ring containing two nitrogen atoms.
Butylstannyl group at the 4-position
A functional group attached to the fourth position of the pyrazole ring This describes the specific location of the butylstannyl group on the pyrazole ring.
Methyl group at the 1-position
A functional group attached to the first position of the pyrazole ring This indicates the presence of a methyl group (a carbon atom with three hydrogen atoms) at the first position of the pyrazole ring.
Organic synthesis
Used in the synthesis of various organic compounds This highlights the compound's role in creating other organic molecules through chemical reactions.
Building block
A starting material for the preparation of other organic compounds This emphasizes the compound's importance as a fundamental component in the synthesis of other molecules.
Biological activities
Exhibits potential antitumor and antifungal properties This refers to the compound's ability to potentially inhibit the growth of tumors and fungi, making it a candidate for further research in these areas.
Check Digit Verification of cas no
The CAS Registry Mumber 179055-21-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,0,5 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 179055-21:
(8*1)+(7*7)+(6*9)+(5*0)+(4*5)+(3*5)+(2*2)+(1*1)=151
151 % 10 = 1
So 179055-21-1 is a valid CAS Registry Number.
179055-21-1Relevant articles and documents
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
Paragraph 0427-0428, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
METHOD FOR PRODUCING 14 GROUP METAL LITHIUM COMPOUND
-
Paragraph 0085; 0087- 0088, (2016/10/31)
PROBLEM TO BE SOLVED: To provide a method for quantitatively producing a group 14 metal lithium compound under a mild condition. SOLUTION: The method for producing a group 14 metal lithium compound represented by formula (4): R4-nMLin comprises reacting a compound represented by formula (1): R4-nMXn and lithium in the presence of a polycyclic aromatic compound represented by formula (2) or formula (3). [In formula (1) and formula (2), R is a hydrocarbon group; M is a metal atom selected from Si, Ge and Sn; X is a halogen atom or R3M- (R and M are the same as mentioned above); and n is 1 or 2] and [R1 is H or a hydrocarbon group; and m is an integer of 0 to 5.] SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT
TRICYCLIC VASOPRESSIN AGONISTS
-
Page 56, (2010/02/08)
-
